Clincosm LogoSign in Get a demo

Bladder Cancer

Showing NaN - NaN of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

Not yet recruiting
  • Bladder Cancer
  • Scottsdale, Arizona
  • +241 more
Feb 9, 2023

Cancer in Patients on Dapagliflozin and Other Antidiabetic

Recruiting
  • Breast Cancer
  • Bladder Cancer
    • Wilmington, Delaware
    • +3 more
    Jan 13, 2023

    Bladder Cancer, Bladder Tumor, Muscle-Invasive Bladder Cancer Trial in Worldwide (Nivolumab, Bempegaldesleukin, Radical

    Active, not recruiting
    • Bladder Cancer
    • +2 more
    • Nivolumab
    • +2 more
    • Gilbert, Arizona
    • +115 more
    Jan 9, 2023

    NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

    Recruiting
    • Non-small Cell Lung Cancer
    • +11 more
    • Birmingham, Alabama
    • +32 more
    Jan 4, 2023

    Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

    Active, not recruiting
    • Melanoma
    • +7 more
    • Scottsdale, Arizona
    • +36 more
    Dec 22, 2022

    Bladder Cancer Trial in Worldwide (Atezolizumab)

    Active, not recruiting
    Has Results
    • Bladder Cancer
    • Birmingham, Alabama
    • +76 more
    Dec 6, 2022

    Bladder Cancer Trial in Worldwide (Atezolizumab)

    Active, not recruiting
    Has Results
    • Bladder Cancer
    • Birmingham, Alabama
    • +76 more
    Dec 6, 2022

    Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in United Kingdom (AVA6000)

    Recruiting
    • Pancreatic Cancer
    • +7 more
    • Glasgow, United Kingdom
    • +5 more
    Nov 24, 2022

    Bladder Cancer Trial in Canada (Tranexamic Acid, Placebo)

    Completed
    • Bladder Cancer
    • Tranexamic Acid
    • Placebo
    • Edmonton, Alberta, Canada
    • +9 more
    Oct 3, 2022

    Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)

    Active, not recruiting
    • Melanoma
    • +9 more
    • MRx0518 Capsules
    • MRx0518/placebo Capsules
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Aug 10, 2022

    Bladder Cancer Trial in Canada, United States (therapeutic conventional surgery, therapeutic standard lymphadenectomy,

    Active, not recruiting
    • Bladder Cancer
    • therapeutic conventional surgery
    • +2 more
    • Los Angeles, California
    • +34 more
    Jul 20, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

    Recruiting
    • Ovarian Cancer
    • +10 more
    • West Hollywood, California
    • +27 more
    Jun 27, 2022

    Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content, Head Neck Cancer Squamous Cell Carcinoma, NSCLC Trial in

    Recruiting
    • Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
    • +12 more
    • Palo Alto, California
    • +9 more
    Mar 24, 2022

    Bladder Cancer Trial in Worldwide (Gemcitabine, E7389, Cisplatin)

    Terminated
    Has Results
    • Bladder Cancer
    • Birmingham, Alabama
    • +41 more
    Feb 3, 2022

    Lung Cancer, Head Neck Cancer, Bladder Cancer Trial in London (S-488210, S-488211)

    Completed
    • Lung Cancer
    • +4 more
    • S-488210
    • S-488211
    • London, United Kingdom
      University College London Clinical Research Facility
    Jan 25, 2022

    Ovary Cancer, Cervix Cancer, Endometrium Cancer Trial in Worldwide (Tisotumab Vedotin (HuMax-TF-ADC))

    Completed
    Has Results
    • Ovary Cancer
    • +7 more
    • Tisotumab Vedotin (HuMax-TF-ADC)
    • Orange, California
    • +28 more
    Nov 29, 2021

    Bladder Cancer, Triple Negative Breast Cancer, Castration-resistant Prostate Cancer Trial in London, Oxford (HMBD-001)

    Recruiting
    • Bladder Cancer
    • +13 more
    • London, United Kingdom
    • +1 more
    Dec 13, 2021

    Bladder Cancer Trial in United Kingdom (Intracorporeal Robot Assisted Radical Cystectomy, Open Radical Cystectomy)

    Active, not recruiting
    • Bladder Cancer
    • Intracorporeal Robot Assisted Radical Cystectomy
    • Open Radical Cystectomy
    • Bristol, United Kingdom
    • +7 more
    Oct 11, 2021

    Oncology, Breast Cancer, Prostate Cancer Trial in Worldwide (Radiation therapy)

    Recruiting
    • Oncology
    • +37 more
    • Radiation therapy
    • Houston, Texas
    • +7 more
    Aug 23, 2021

    Bladder Cancer Trial in Canada (Durvalumab, Immune Modulating Radiation)

    Recruiting
    • Bladder Cancer
    • Edmonton, Alberta, Canada
    • +3 more
    Jun 14, 2021

    Hematuria, Bladder Cancer, Bladder Disease Trial in London (Modified Cystoscopy, Routine Cystoscopy)

    Completed
    • Hematuria
    • +2 more
    • Modified Cystoscopy
    • Routine Cystoscopy
    • London, Ontario, Canada
      London Health Sciences Centre
    Apr 26, 2021

    Ovary Cancer, Cervix Cancer, Endometrium Cancer Trial in Worldwide (Tisotumab vedotin (HuMax-TF-ADC))

    Completed
    Has Results
    • Ovary Cancer
    • +6 more
    • Tisotumab vedotin (HuMax-TF-ADC)
    • Houston, Texas
    • +15 more
    Mar 15, 2021

    Bladder Cancer Trial in Canada, United States (drug, procedure, radiation)

    Completed
    • Bladder Cancer
    • Birmingham, Alabama
    • +228 more
    Oct 19, 2020

    Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Worldwide (Rucaparib)

    Terminated
    Has Results
    • Bladder Cancer
    • +7 more
    • Scottsdale, Arizona
    • +63 more
    Oct 16, 2020